Gujarat Inject (Kerala) Ltd - Stock Valuation and Financial Performance

BSE: 524238 | NSE: | Pharmaceuticals & Drugs | Small Cap

Guj. Inject (Kerala) Share Price

28.20 0.11 0.39%
as on 21-Feb'25 16:59

DeciZen - make an informed investing decision on Guj. Inject (Kerala)

M-Cap below 100cr DeciZen not available

Gujarat Inject (Kerala) stock performance -

P/E Ratio (SA):
42.11
Market Cap:
41.3 Cr.
52-wk low:
8.7
52-wk high:
28.7

Is Gujarat Inject (Kerala) Ltd an attractive stock to invest in?

1. Is Gujarat Inject (Kerala) Ltd a good quality company?

Past 10 year’s financial track record analysis by Moneyworks4me indicates that Gujarat Inject (Kerala) Ltd is a below average quality company.

2. Is Gujarat Inject (Kerala) Ltd undervalued or overvalued?

The key valuation ratios of Gujarat Inject (Kerala) Ltd's currently when compared to its past seem to suggest it is in the Somewhat Undervalued zone.

3. Is Gujarat Inject (Kerala) Ltd a good buy now?

The Price Trend analysis by MoneyWorks4Me indicates it is Weak which suggest that the price of Gujarat Inject (Kerala) Ltd is likely to Fall in the short term. However, please check the rating on Quality and Valuation before investing.

10 Year X-Ray of Guj. Inject (Kerala):

Analysis of Financial Track Record

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end
Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end

Data adjusted to bonus, split, extra-ordinary income, rights issue and change in financial year end.

Financial track record gives insight into the company's performance on key parameters over the past ten years. MoneyWorks4me’s proprietary colour codes make it easy for retail investors to gauge the company’s past performance.
Gujarat Inject (Kerala) Ltd has not performed well majority of the past ten years indicating its past ten year financial track record is not good

Value Creation

Value Creation Index Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
ROCE %
0%0%0%0%0%0%0%0%0%2.5%-
Value Creation
Index
NANANANANANANANANA-0.8-

Growth Parameters

Growth Parameters Colour Code Guide

Sales
001.6000000.25.820
Sales YoY Gr.
-NA7,750%-100%NANANA100%750%3,305.9%-
Adj EPS
-01.40-0-00-0.200.10.10.7
YoY Gr.
-NA-99.3%-400%NANANANANA-12.5%-
BVPS (₹)
-6.3-1.6-1.5-1.6-1.6-1.6-1.8-1.8-1.756.8
Adj Net
Profit
00.70000-0.1000.11
Cash Flow from Ops.
000000-0.100.1-6-
Debt/CF from Ops.
-3326.1-1797.7-555.5-56.4415.12678.1-6.5-741.511.60-

CAGR

CAGR Colour Code Guide

9 Years 5 Years 3 Years 1 Years
Sales NANA733.5%3305.9%
Adj EPS NANANA-12.5%
BVPSNANANANA
Share Price - - - 98.2%

Key Financial Parameters

Performance Ratio Colour Code Guide

Mar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24TTM
Return on
Equity %
0.1-36.2-0.82.20.7-012.7-0.3-4.82.211.4
Op. Profit
Mgn %
04.10.6000-982.2-200.2-2170.85.1
Net Profit
Mgn %
04159.90.4000-911.29.823.61.44.9
Debt to
Equity
-0.9-0.7-0.8-0.8-0.8-0.8-0.8-0.8-0.70-
Working Cap
Days
03,1531600011951131218973
Cash Conv.
Cycle
0-6,395-200004896-331-1561

Recent Performance Summary

Return on Equity has increased versus last 3 years average to 11.40%

Sales growth is growing at healthy rate in last 3 years 733.48%

Sales growth is good in last 4 quarters at 814.62%

Net Profit has been subdued in last 3 years 0.00%

Latest Financials - Gujarat Inject (Kerala) Ltd.

Standalone Consolidated
TTM EPS (₹) 0.7 -
TTM Sales (₹ Cr.) 20.2 -
BVPS (₹.) 6.8 -
Reserves (₹ Cr.) -5 -
P/BV 4.15 -
PE 42.11 -
From the Market
52 Week Low / High (₹) 8.74 / 28.65
All Time Low / High (₹) 0.75 / 50.00
Market Cap (₹ Cr.) 41.3
Equity (₹ Cr.) 14.7
Face Value (₹) 10
Industry PE 37.5

Quarterly Results

 Mar'24 YoY Gr. Rt. %Jun'24 YoY Gr. Rt. %Sep'24 YoY Gr. Rt. %Dec'24 YoY Gr. Rt. %
Sales (₹ Cr.) 32.5 73.723.4 95.523.7 68.943.1 30.9
Adj EPS (₹) 0.6 -74.50.3 -43.40.6 -40.93 -16.4
Op. Profit Mgn % 25.78 -2573 bps27.08 -1020 bps19.20 -841 bps39.68 211 bps
Net Profit Mgn % 4.72 -2291 bps3.26 -650 bps6.03 -895 bps17.76 -683 bps

Management X-Ray of Guj. Inject (Kerala):

Shareholding Pattern

JavaScript chart by amCharts 3.21.5
JavaScript chart by amCharts 3.21.5Promoters:0%Institutions:0%Non-Institutions:100%

Promoter's Holding & Share Pledging

JavaScript chart by amCharts 3.21.5Sep22Dec22Mar23Jun23Sep23Dec23Mar24Jun24Sep24Dec240%2%4%6%8%10%
Pledged *0.000.000.000.000.000.000.000.000.000.00
* Pledged shares as % of Promoter's holding (%)

Valuation of Guj. Inject (Kerala)

MRP
spaceLock icon
MOS
spaceLock icon%
DP
spaceLock icon
Base EPS
spaceLock icon
DPS
spaceLock icon
MRP: ₹ 0
DP: ₹0
Base EPS ₹:
DPS ₹:
MOS (%):
Expected EPS Growth Rate:
0%
Base 0%
50%
Expected Rate of Return:
0%
Base 0%
50%
Future PE:
0
Base 0
200
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max
YTD 1Y 3Y 5Y 10Y Max

Event Update

Login/Register to view analysis.

Analyst's Notes

No data found!

Key Ratios of Guj. Inject (Kerala)

Adj EPS (Rs.)

Sales (Cr.)

ROE (%)

ROCE (%)

Company Name CMP(₹)
Change ₹(%)
Market Cap
Net Sales (₹ Cr.)
Latest EPS (₹)
Net Profit Margin %
Latest P/E
Latest P/BV
Alembic Pharma 802.8 -10.6 (-1.3%) Small Cap 6,229 30.8 9.6 26.4 3.2
Laurus Labs 521.1 -15.4 (-2.9%) Small Cap 5,041 3.7 3.1 144.5 6.9
Piramal Pharma 208.6 -9.5 (-4.3%) Small Cap 4,390 5.2 8.4 42.1 4.1
Ajanta Pharma 2,607.3 -63.1 (-2.4%) Small Cap 4,209 71.9 19 37.2 8.5
Gland Pharma 1,524.3 3.9 (0.3%) Small Cap 4,167 68.1 24.8 22.3 2.7
Natco Pharma 797.8 4.8 (0.6%) Small Cap 3,999 104.1 34.5 7.6 2
Granules India 509 -18.4 (-3.5%) Small Cap 3,755 13.3 11.7 39.7 3.9
Emcure Pharma 996.8 5.2 (0.5%) Small Cap 3,498 8.5 4.4 116.8 6.5
JB Chem & Pharma 1,605.5 -25 (-1.5%) Small Cap 3,299 40.4 16.1 40.4 7.7
Sanofi India 5,076.8 -91.3 (-1.8%) Small Cap 2,851 184.4 20.8 28 15.5
Shows rows:

Profit And Loss

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Sales00.021.570000.010.020.175.79
Operating Expenses 00.021.560.070.020.010.120.070.555.74
Manufacturing Costs000.010000000
Material Costs001.510000.010.020.155.40
Employee Cost 00.010.010.020.01000.010.030.03
Other Costs 00.010.030.050.0100.110.040.370.31
Operating Profit 000.01-0.07-0.02-0.01-0.11-0.05-0.380.04
Operating Profit Margin (%) -4.1%0.6%----982.0%-200.0%-217.0%0.8%
Other Income 0000.050.020.010.010.050.430.06
Interest 0000000000
Depreciation 0000000000
Exceptional Items 02.3000000000
Profit Before Tax 02.300.01-0.02-0.010-0.1100.060.11
Tax 000000000.010.02
Profit After Tax 02.300.01-0.02-0.010-0.1100.040.08
PAT Margin (%) -13,860.5%0.4%----911.0%9.8%23.6%1.4%
Adjusted EPS (₹)0.04.70.00.00.00.0-0.20.00.10.1
Dividend Payout Ratio (%)0%0%0%0%0%0%0%0%0%0%

Balance Sheet

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24

Equity and Liabilities

Shareholders Fund -3.06-0.76-0.75-0.77-0.78-0.78-0.88-0.88-0.845.65
Share Capital 4.884.884.884.884.884.884.884.884.8811.29
Reserves -7.95-5.64-5.64-5.66-5.66-5.66-5.77-5.76-5.72-5.64
Minority Interest0000000000
Debt2.870.560.570.590.590.590.690.730.610
Long Term Debt0.310.310.310.310.310.310.420.420.420
Short Term Debt2.550.250.250.280.280.280.280.320.190
Trade Payables0.170.170000000.320.11
Others Liabilities 0.200.200.200.200.200.200.210.210.212.92
Total Liabilities 0.170.170.010.020.010.010.020.060.308.69

Fixed Assets

Gross Block0000000000
Accumulated Depreciation0000000000
Net Fixed Assets0000000000
CWIP 0000000000
Investments 0000000000
Inventories00000000.0100
Trade Receivables0000000000
Cash Equivalents 0.020.020.020.010.010.010.010.010.062.92
Others Assets0.140.14-0.010.010000.050.245.77
Total Assets 0.170.170.010.020.010.010.020.060.308.69

Cash Flow

(All Figures are in Crores.)
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Cash Flow From Operating Activity 000-0.0100-0.1100.05-6.03
PBT 000.01-0.02-0.010-0.1100.060.11
Adjustment 0000000000
Changes in Working Capital 0-2.3-0.010.010.010-0-00.01-6.11
Tax Paid 00000000-0.01-0.02
Cash Flow From Investing Activity 0000000000
Capex 0000000000
Net Investments 0000000000
Others 0000000000
Cash Flow From Financing Activity 0000000.10008.88
Net Proceeds from Shares 0000000009.30
Net Proceeds from Borrowing 0000000.1000-0.42
Interest Paid 0000000000
Dividend Paid 0000000000
Others 0000000000
Net Cash Flow 000-0.0100000.052.86
PARTICULARSMar'15Mar'16Mar'17Mar'18Mar'19Mar'20Mar'21Mar'22Mar'23Mar'24
Ratios
ROE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/A3.44
ROCE (%)N/AN/AN/AN/AN/AN/AN/AN/AN/A2.54
Asset Turnover Ratio00.117.360000.730.550.941.29
PAT to CFO Conversion(x)N/A00N/AN/AN/AN/AN/A1.25-75.38
Working Capital Days
Receivable Days0000000000
Inventory Days000000979600
Payable Days0000000076515

Gujarat Inject (Kerala) Ltd Stock News

Gujarat Inject (Kerala) Ltd FAQs

Company share prices are keep on changing according to the market conditions. The closing price of Guj. Inject (Kerala) on 21-Feb-2025 16:59 is ₹28.20.
Market capitalization or market cap is determined by multiplying the current market price of a company's shares with the total number of shares outstanding. As of 21-Feb-2025 16:59 the market cap of Guj. Inject (Kerala) stood at ₹41.31.
The latest P/E ratio of Guj. Inject (Kerala) as of 21-Feb-2025 16:59 is 42.11.
The latest P/B ratio of Guj. Inject (Kerala) as of 21-Feb-2025 16:59 is 4.15.
The 52-week high of Guj. Inject (Kerala) is ₹28.65 and the 52-week low is ₹8.74.
The TTM revenue is Trailing Twelve Months sales. The TTM revenue/sales of Guj. Inject (Kerala) is ₹20.23 ( Cr.) .

About Gujarat Inject (Kerala) Ltd

Gujarat Inject (Kerala) (GKIL) was incorporated on January 7, 1991 and obtained certificate for commencement of business on February 14, 1991. The company has been jointly promoted by the Kerala State Industrial Development Corporation (KSIDC), a wholly owned subsidiary of Government of Kerala undertaking and Gujarat Inject (GIL) and its associates. The company has received SIA registration to manufacture intravenous solutions at puddussey east, kanjikode, in palghat district in Kerala.

The company was established  to produce, manufacture, buy, sell, import, export, stock, distribute and deal in all kinds of pharmaceuticals products including bulk drugs and formulation chemicals, medicinal preparation, intravenous fluids, infusion and transfusion solutions, vitamin and non vitamin tablets, capsules, liquids and also medical equipments/ instruments such as disposable plastic bottles, surgical sets, infusion and transfusion sets, disposable syringes diagnostic kits.

Read More Read Less
You have 1 views remaining as a Guest User. To get DeciZen Rating of 3,500+ Stocks based on their Quality, Valuation and Price Trend Login Now
© 2025 The Alchemists Ark Pvt. Ltd. All rights reserved. MoneyWorks4Me ® is a registered trademark of The Alchemists Ark Pvt. Ltd.
Loading...
Hold on